Status:
COMPLETED
Assessing the Efficacy of Self-Driven Repetitive Artmaking Practice
Lead Sponsor:
Montefiore Medical Center
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Chronic Pain
Opioid Use Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The primary purpose of this study is to assess the acceptability of self-directed art making for people with chronic pain and OUD/opioid misuse, or to state it another way, whether people with chronic...
Detailed Description
The pilot is an exploratory evaluation of whether repetitive artmaking in home environments is acceptable for chronic pain self-management in individuals with OUD/opioid misuse, and whether self-drive...
Eligibility Criteria
Inclusion
- Experience chronic pain
- Have received medication for OUD in the past 30 days or meet criteria for opioid misuse
- Are aged 18 or older
- Are fluent in English and/or Spanish
Exclusion
- Are not fluent in either English or Spanish
- Are unable to participate in and complete the introductory workshop due to language or other barriers - physical disabilities are not exclusionary
- Do not otherwise meet the inclusion criteria for age, OUD, Opioid misuse, and chronic pain.
Key Trial Info
Start Date :
July 2 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 5 2025
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT06554431
Start Date
July 2 2024
End Date
January 5 2025
Last Update
June 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Montefiore Wellness Center at Waters Place
The Bronx, New York, United States, 10461